Abstract
Some years ago the Rutgers Interdisciplinary Research Center received what then seemed to be a very large grant to study the hypothesis that nicotinic acid in large doses was effective in the treatment of schizophrenia (Hoffer et al., 1957). The research plan for this comprehensive study provided for a sample of 100 patients on treatment for the course of two years. All of the patients were new admissions at the New Jersey State Hospital at Marlboro. All were males and very few of them could be described as chronic patients. The median duration of prior hospitalization during the preceding five years was 7 1/2 weeks.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hoffer, A., Osmond, H., Callbeck, M. J., and Kahan, I., 1957, “Treatment of schizophrenia with nicotinic acid and nicotinamide,” J. Clin. Exp. Psychopathol. 18: 131–158.
Brown, J., and Winkelmann, R. K., 1968, “Acanthosis nigricans: A study of 90 cases,” Medicine 47:33–51.
Wittenborn, J. R., Weber, E. S. P., and Brown, M.,1973, “Niacin in the long-term treatment of schizophrenia,” Arch. Gen. Psychiat. 28:308–315.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Wittenborn, J.R. (1975). Premorbid Adjustment and Response to Nicotinic Acid. In: Serban, G. (eds) Nutrition and Mental Functions. Advances in Behavioral Biology, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3075-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3075-2_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3077-6
Online ISBN: 978-1-4684-3075-2
eBook Packages: Springer Book Archive